Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margalida Rotger

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Plos Pathogens|March 3, 2010
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individualsMargalida Rotger, Kristen K Dang, Jacques Fellay, et al.
Journal of Virology|May 11, 2018
The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species SpecificVeronika Lodermeyer, George Ssebyatika, Vânia Passos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 11, 2015
In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal FluidManel Aouri, Catalina Barcelo, Béatrice Ternon, et al.
Pharmacogenetics and Genomics|December 14, 2007
Promoter polymorphisms and allelic imbalance in ABCB1 expressionCorinne Loeuillet, Michael Weale, Samuel Deutsch, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal studyMargalida Rotger, Cornelia Bayard, Patrick Taffé, et al.
Open Forum Infectious Diseases|July 16, 2016
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort StudyThomas Junier, Margalida Rotger, Emmanuel Biver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2010
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individualsMargalida Rotger, Thomas Gsponer, Raquel Martinez, et al.
Ebiomedicine|August 20, 2015
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic AnalysisNathan W Cummins, Jacqueline Neuhaus, Haitao Chu, et al.
The Journal of Infectious Diseases|April 6, 2005
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disordersPhilip E Tarr, Patrick Taffé, Gabriela Bleiber, et al.
Plos One|January 12, 2012
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapyTracy R Glass, Margalida Rotger, Amalio Telenti, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Plos Pathogens|March 3, 2010
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individualsMargalida Rotger, Kristen K Dang, Jacques Fellay, et al.
Journal of Virology|May 11, 2018
The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species SpecificVeronika Lodermeyer, George Ssebyatika, Vânia Passos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 11, 2015
In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal FluidManel Aouri, Catalina Barcelo, Béatrice Ternon, et al.
Pharmacogenetics and Genomics|December 14, 2007
Promoter polymorphisms and allelic imbalance in ABCB1 expressionCorinne Loeuillet, Michael Weale, Samuel Deutsch, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal studyMargalida Rotger, Cornelia Bayard, Patrick Taffé, et al.
Open Forum Infectious Diseases|July 16, 2016
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort StudyThomas Junier, Margalida Rotger, Emmanuel Biver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2010
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individualsMargalida Rotger, Thomas Gsponer, Raquel Martinez, et al.
Ebiomedicine|August 20, 2015
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic AnalysisNathan W Cummins, Jacqueline Neuhaus, Haitao Chu, et al.
The Journal of Infectious Diseases|April 6, 2005
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disordersPhilip E Tarr, Patrick Taffé, Gabriela Bleiber, et al.
Plos One|January 12, 2012
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapyTracy R Glass, Margalida Rotger, Amalio Telenti, et al.
Pageof 5